Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Anoctamin 2 identified as an autoimmune target in multiple sclerosis
KTH, School of Biotechnology (BIO), Proteomics and Nanobiotechnology.ORCID iD: 0000-0001-7843-2960
KTH, School of Biotechnology (BIO), Proteomics and Nanobiotechnology.ORCID iD: 0000-0002-4657-8532
2016 (English)In: Multiple Sclerosis, ISSN 1352-4585, E-ISSN 1477-0970, Vol. 22, 10-10 p.Article in journal, Meeting abstract (Other academic) Published
Resource type
Text
Place, publisher, year, edition, pages
2016. Vol. 22, 10-10 p.
National Category
Neurology
Identifiers
URN: urn:nbn:se:kth:diva-184559ISI: 000371657100022OAI: oai:DiVA.org:kth-184559DiVA: diva2:916997
Conference
ACTRIMS Forum, FEB 18-20, 2016, New Orleans, LA
Note

QC 20160405

Available from: 2016-04-05 Created: 2016-04-01 Last updated: 2016-04-05Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Ayoglu, BurcuNilsson, Peter
By organisation
Proteomics and Nanobiotechnology
In the same journal
Multiple Sclerosis
Neurology

Search outside of DiVA

GoogleGoogle Scholar

Total: 47 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf